A detailed history of Zebra Capital Management LLC transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Zebra Capital Management LLC holds 6,600 shares of PTCT stock, worth $258,917. This represents 1.6% of its overall portfolio holdings.

Number of Shares
6,600
Holding current value
$258,917
% of portfolio
1.6%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

BUY
$38.16 - $48.86 $251,855 - $322,476
6,600 New
6,600 $320,000
Q1 2022

May 16, 2022

SELL
$33.33 - $44.6 $261,807 - $350,333
-7,855 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$35.36 - $41.86 $102,402 - $121,226
-2,896 Reduced 26.94%
7,855 $313,000
Q3 2021

Nov 15, 2021

BUY
$37.01 - $44.74 $397,894 - $480,999
10,751 New
10,751 $400,000

Others Institutions Holding PTCT

About PTC THERAPEUTICS, INC.


  • Ticker PTCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,541,000
  • Market Cap $2.81B
  • Description
  • PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...
More about PTCT
Track This Portfolio

Track Zebra Capital Management LLC Portfolio

Follow Zebra Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zebra Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Zebra Capital Management LLC with notifications on news.